New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Learn More
Last Close
Oct 17  •  04:00PM ET
1.73
Dollar change
-0.05
Percentage change
-2.81
%
Index- P/E- EPS (ttm)-1.57 Insider Own66.51% Shs Outstand161.95M Perf Week-8.47%
Market Cap280.17M Forward P/E- EPS next Y-1.01 Insider Trans0.00% Shs Float54.24M Perf Month10.19%
Enterprise Value82.54M PEG- EPS next Q-0.33 Inst Own22.98% Short Float12.49% Perf Quarter-11.73%
Income-252.09M P/S- EPS this Y7.62% Inst Trans-7.65% Short Ratio7.80 Perf Half Y167.47%
Sales0.00M P/B1.53 EPS next Y28.56% ROA-80.25% Short Interest6.78M Perf YTD-83.68%
Book/sh1.13 P/C1.29 EPS next 5Y14.93% ROE-89.37% 52W High17.19 -89.93% Perf Year-89.24%
Cash/sh1.34 P/FCF- EPS past 3/5Y0.69% - ROIC-124.38% 52W Low0.61 183.14% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility5.43% 7.25% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM9.84% Oper. Margin- ATR (14)0.12 Perf 10Y-
Dividend Ex-Date- Quick Ratio10.54 Sales Y/Y TTM- Profit Margin- RSI (14)46.49 Recom2.50
Dividend Gr. 3/5Y- - Current Ratio10.54 EPS Q/Q11.67% SMA20-5.00% Beta2.89 Target Price7.00
Payout- Debt/Eq0.11 Sales Q/Q- SMA501.56% Rel Volume0.22 Prev Close1.78
Employees110 LT Debt/Eq0.11 EarningsAug 06 AMC SMA20020.27% Avg Volume868.23K Price1.73
IPOSep 15, 2023 Option/ShortYes / Yes EPS/Sales Surpr.8.99% - Trades Volume195,039 Change-2.81%
Date Action Analyst Rating Change Price Target Change
Sep-16-25Downgrade JP Morgan Neutral → Underweight
Apr-02-25Downgrade BofA Securities Buy → Underperform $1
Mar-10-25Downgrade William Blair Outperform → Mkt Perform
Mar-07-25Downgrade Stifel Buy → Hold $6 → $2
Mar-07-25Downgrade Guggenheim Buy → Neutral
Jan-02-25Downgrade RBC Capital Mkts Outperform → Sector Perform $29 → $4
Nov-05-24Downgrade JP Morgan Overweight → Neutral $18 → $15
Oct-01-24Initiated H.C. Wainwright Buy $30
Jul-22-24Initiated Needham Buy $23
Jul-08-24Initiated Mizuho Outperform $20
Oct-01-25 07:00AM
Sep-17-25 09:40AM
Sep-16-25 09:35AM
Sep-02-25 07:00AM
Aug-20-25 12:13AM
05:07AM Loading…
Aug-08-25 05:07AM
Aug-06-25 04:05PM
Jul-29-25 10:23AM
Jul-23-25 07:00AM
Jul-20-25 12:35AM
Jul-09-25 07:00AM
May-13-25 03:10AM
May-12-25 04:01PM
Apr-28-25 07:00AM
Apr-22-25 02:49AM
04:10PM Loading…
Apr-21-25 04:10PM
Mar-18-25 05:45AM
Mar-07-25 12:26PM
07:08AM
Mar-04-25 08:30AM
06:25AM
Mar-03-25 07:00AM
Feb-28-25 05:45AM
Feb-26-25 08:46PM
Feb-25-25 05:45AM
Feb-18-25 05:45AM
Feb-13-25 10:33AM
07:00AM
Feb-11-25 05:45AM
Jan-04-25 08:00AM
07:20AM Loading…
Jan-03-25 07:20AM
Jan-02-25 05:07PM
04:22PM
01:28PM
01:07PM
12:00PM
10:47AM
09:59AM
09:54AM
08:30AM
07:00AM
Nov-19-24 08:53AM
Nov-12-24 07:00AM
Nov-06-24 07:00AM
Oct-29-24 07:00AM
Aug-14-24 07:00AM
Aug-06-24 01:54PM
07:00AM
Jul-01-24 01:00AM
Jun-20-24 07:00AM
May-14-24 08:52AM
07:00AM
May-07-24 01:54PM
10:20AM
07:00AM
May-06-24 07:00AM
Apr-16-24 11:28AM
Apr-15-24 04:20PM
12:17PM
08:45AM
07:47AM
06:36AM
06:30AM
Mar-13-24 07:00AM
Mar-07-24 02:52PM
07:00AM
Jan-22-24 07:00AM
Jan-10-24 08:32AM
Jan-02-24 07:00AM
Dec-17-23 12:35PM
Dec-12-23 07:00AM
Nov-27-23 07:00AM
Nov-01-23 07:00AM
Oct-30-23 07:00AM
Oct-10-23 07:00AM
Sep-28-23 07:54PM
Sep-27-23 06:50PM
Sep-18-23 12:35PM
Sep-14-23 08:49PM
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Henry GosebruchOfficerMar 12 '25Proposed Sale1.4315,00021,450Mar 12 04:49 PM
BERNS PAUL LSee RemarksFeb 18 '25Sale1.6913,87123,4687,405,004Feb 20 05:14 PM
Milligan Michael LeeSee RemarksFeb 18 '25Sale1.691,9783,35122,470Feb 20 05:14 PM
Aurora Daljit SinghChief Strategy OfficerFeb 18 '25Sale1.688,56514,34788,935Feb 20 05:13 PM
Lenz Robert A.Head of R&DFeb 18 '25Sale1.675,6149,383309,092Feb 20 05:12 PM
Pinto JoshuaPresidentFeb 18 '25Sale1.678,04813,47776,952Feb 20 05:11 PM
Suh Carol Y.OfficerFeb 18 '25Proposed Sale1.689,54016,020Feb 18 05:51 PM
Milligan Michael LeeOfficerFeb 18 '25Proposed Sale1.691,9783,351Feb 18 05:49 PM
Pinto JoshuaOfficerFeb 18 '25Proposed Sale1.678,04813,478Feb 18 05:45 PM
Lenz Robert A.OfficerFeb 18 '25Proposed Sale1.675,6149,383Feb 18 05:43 PM
Gosebruch Henry OOfficerFeb 18 '25Proposed Sale1.676,85711,462Feb 18 05:41 PM
BERNS PAUL LOfficerFeb 18 '25Proposed Sale1.6913,87123,468Feb 18 05:40 PM
Aurora Daljit SinghOfficerFeb 18 '25Proposed Sale1.688,56514,348Feb 18 05:38 PM